Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Sarepta Shares Get a 35% Boost from FDA Approval of 2nd DMD Drug

Sarepta Therapeutics shares traded 35% higher after the firm reported that the FDA approved its second RNA exon-skipping treatment drug VYONDYS 53 injection for the treatment of Duchenne's Muscular Dystrophy in patients amenable to skipping Exon 53. Yesterday evening,...
Streetwise Reports | December 16, 2019 |

Barrick Offers to Buy Rest of Project to Resolve Government Dispute

The situation and the gold major's proposal are discussed in a Haywood report. In a May 23 research note, Haywood analyst Kerry Smith reported that Barrick Gold Corp. (ABX:TSX; GOLD:NYSE) proposed to acquire the remaining 36.1% interest in Acacia, taking Barrick ...
Streetwise Reports | May 31, 2019 |

Sanofi Pays Lexicon Pharma $260 Million to Settle Diabetes Drug Dispute

Lexicon Pharmaceuticals shares traded higher by more than 30% today after the company announced termination of its alliance with Sanofi SA and a $260 million settlement over its diabetes drug Zynquista. Yesterday afternoon, The Woodlands, Tex.-based Lexicon Pharmaceu...
Streetwise Reports | September 12, 2019 |

Defense Metals on track to build rare earth mine

Those who have worked in the business as long as I have will easily remember the rare earth mania of 2008-11. For about three years following China’s export restrictions on rare earth elements, which hiked the prices of REEs to record highs, the junior resour...
Richard (Rick) Mills | February 27, 2019 |

The Company That’s Delivering Safe, Evidence-Based Psychedelic-Assisted Psychotherapies

(Click image to play podcast) Stockhouse investors who are dialed into the not-only nascent but now, pardon the pun, mushrooming psychedelics sector are likely familiar with a mental health and wellness company “centred on developing and supporting the safe, ev...
Dave Jackson | October 8, 2020 |

BAT, Barrick Gold, Osino Resources: Supposed political risks, a burden, and an opportunity

Businesses, like citizens, operate within the regulatory framework. In this way, the state guarantees peaceful coexistence. But what if the legal framework changes? It is easy for individuals to adapt to new circumstances. It can be more challenging for companies - for example...
Nico Popp | October 1, 2020 |

How to Buy Gold Stocks

Gold is one of the most sought after precious metals on earth. It has been, historically and culturally, a symbol of wealth and status (with majority of the demand coming from jewelry production), while also having an important function within the global financial structure. W...
Stockhouse Editorial | July 24, 2019 |

How This Food Investment Company is Making the Plant-based Sector Accessible

Interest in plant-based products is hotter now more than ever, and companies in this sector are busy ramping up their efforts to meet the demand from consumers as the switch to more sustainable lifestyles continues to grow. Eat Well Investment Group Inc. ( CSE:EWG , ...
Jocelyn Aspa | February 3, 2022 |

Stocks facing revaluation: Nel, Bayer, Power Nickel with potential

Relief for Bayer. In the U.S., the company has won a victory in the dispute over compensation for illnesses caused by the chemical PCB. Is it groundbreaking and the start of a revaluation of the stock? A revaluation already seems to be underway at Power Nickel. Follo...
Fabian Lorenz | May 9, 2024 |

BioNTech & Cardiol Therapeutics – on the verge of a breakout

Compared with the broader indices, DAX and Dow Jones, which have already reached new all-time highs, the Nasdaq Biotech Index is currently lagging. The sector index is still around 23% below its peak from August 2021. Nevertheless, the sector is on the move. In addition t...
Stefan Feulner | May 22, 2024 |
1 2 3 4 5 6 7 8 9 10 ...